Abstract
Posterior vitreous detachment (PVD) is commonly seen in the aging eye [1]. Although the majority of PVDs occur without complication, a small proportion can be associated with excessive traction on the macula, resulting in retinal anatomic changes. These eyes are characterized as having vitreomacular traction (VMT). VMT can lead to functional changes such as metamorphopsia and blurring of visual acuity with central visual field defects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Foos RY, Wheeler NC. Vitreoretinal juncture. Synchysis senilis and posterior vitreous detachment. Ophthalmology. 1982;89:1502–12.
Stalmans P, Benz MS, Gandorfer A, et al. Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. N Engl J Med. 2012;367:606–15.
Jackson TL, Nicod E, Anglis A, et al. Pars plana vitrectomy for vitreomacular traction syndrome: a systemic review and metaanalysis of safety and efficacy. Retina. 2013;33:2012–7.
Tzu JH, John VJ, Flynn HW Jr, et al. Clinical course of vitreomacular traction managed initially by observation. Ophthalmic Surg Lasers Imaging. Retina. 2015;46:571–6.
Gaudric A, Haouchine B, Massin P, et al. Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol 1999;117:744-51.
Bishop PN. Structural macromolecules and supramolecular organisation of the vitreous gel. Prog Retin Eye Res. 2000;19:323–44.
Sebag J. Vitreous: the resplendent enigma. Br J Ophthalmol. 2009;93:989–91.
Uchino E, Uemura A, Ohba N. Initial stages of posterior vitreous detachment in healthy eyes of older persons evaluated by optical coherence tomography. Arch Ophthalmol. 2001;119:1475–9.
Johnson MW. Posterior vitreous detachment: evolution and complications of its early stages. Am J Ophthalmol. 2010;149:371–82.
Sebag J. Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol. 2004;242:690–8.
Reese AB, Jones IR, Cooper WC. Macular changes secondary to vitreous traction. Am J Ophthalmol. 1967;64:544–9.
Reese AB, Jones IR, Cooper WC. Vitreomacular traction syndrome confirmed histologically. Am J Ophthalmol. 1970;69:975–7.
Duker JS, Kaiser PK, Binder S, et al. The International Vitreomacular Traction Study Group classification of vitreomacular adhesion, traction, and macular hole. Ophthalmology. 2013;120:2611–9.
Hikichi T, Yoshida A, Trempe CL. Course of vitreomacular traction syndrome. Am J Ophthalmol. 1995;119:55–61.
Theodossiadis GP, Grigoropoulos VG, Theodoropoulou S, et al. Spontaneous resolution of vitreomacular traction demonstrated by spectral-domain optical coherence tomography. Am J Ophthalmol. 2014;157:842–51.
Almeida DR, Chin EK, Rahim K, et al. Factors associated with spontaneous release of vitreomacular traction. Retina. 2015;35:492–7.
Singh RP, Li A, Bedi R, et al. Anatomical and visual outcomes following ocriplasmin treatment for symptomatic vitreomacular traction syndrome. Br J Ophthalmol. 2014;98:356–60.
Sharma P, Juhn A, Houston SK, et al. Efficacy of intravitreal ocriplasmin on vitreomacular traction and full-thickness macular holes. Am J Ophthalmol. 2015;159:861–7.
Warrow DJ, Lai MM, Patel A, et al. Treatment outcomes and spectral-domain optical coherence tomography findings of eyes with symptomatic vitreomacular adhesion treated with intravitreal ocriplasmin. Am J Ophthalmol. 2015;159:20–30.
Rodrigues IA, Stangos AN, McHugh DA, et al. Intravitreal injection of expansile perfluoropropane (c(3)f(8)) for the treatment of vitreomacular traction. Am J Ophthalmol. 2013;155:270–6.
Steinle NC, Dhoot DS, Quezada Ruiz C, et al. Treatment of vitreomacular traction with intravitreal perfluoropropane (C3f8) injection. Retina. 2017;37:643–50.
Chang JS, Smiddy WE. Cost evaluation of surgical and pharmaceutical options in treatment for vitreomacular adhesions and macular holes. Ophthalmology. 2014;121:1720–6.
Neffendorf JE, Gupta B, Williamson TH. Intraoperative complications of patients undergoing small-gauge and 20-gauge vitrectomy: a database study of 4,274 procedures. Eur J Ophthalmol. 2017;27:226–30.
Ichiyama Y, Kawamura H, Fujikawa M, et al. Photoreceptor outer segment length and outer foveal thickness as factors associated with visual outcome after vitrectomy for vitreomacular traction syndrome. Retina. 2016;36:1707–12.
Petrou P, Kontos A, Errera MH, et al. Pars plana vitrectomy for vitreomacular traction syndrome: analysing the preoperative prognostic factors. Semin Ophthalmol. 2016;9:1–5.
Yang CS, Hsieh MH, Chang YF, et al. Predictive factors of visual outcome for vitreomacular traction syndrome after vitrectomy. Retina. 2018;38:1533.
Park DW, Dugel PU, Garda J, et al. Macular pucker removal with and without internal limiting membrane peeling: pilot study. Ophthalmology. 2003;110:62–4.
Obata S, Fujikawa M, Iwasaki K, et al. Changes in retinal thickness after vitrectomy for epiretinal membrane with and without internal limiting membrane peeling. Ophthalmic Res. 2017;57:135–40.
Kumagai K, Ogino N, Furukawa M, et al. Retinal thickness after vitrectomy and internal limiting membrane peeling for macular hole and epiretinal membrane. Clin Ophthalmol. 2012;6:679–88.
Ripandelli G, Scarinci F, Piaggi P, et al. Macular pucker: to peel or not to peel the internal limiting membrane? A microperimetric response. Retina. 2015;35:498–507.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ichiyama, Y., Ohji, M. (2019). Vitreomacular Traction Syndrome. In: Ohji, M. (eds) Surgical Retina. Retina Atlas. Springer, Singapore. https://doi.org/10.1007/978-981-13-6214-9_2
Download citation
DOI: https://doi.org/10.1007/978-981-13-6214-9_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-6213-2
Online ISBN: 978-981-13-6214-9
eBook Packages: MedicineMedicine (R0)